Having trouble viewing this email? View in your browser.

11 July 2017

Dear colleagues,

Until 24 August you may access for free an article the ESCMID study group on antimicrobial stewardship ESGAP published on how healthcare systems can promote responsible antimicrobial use.

Please fill in a survey on usability of the clinical data website launched by the European Medicines Agency (EMA) in line with its policy on the publication of clinical data in October 2016. EMA is the first regulatory authority worldwide to provide broad access to clinical data submitted by pharmaceutical companies to support their marketing applications for human medicines.


ASM/ESCMID AMR conference from 6 – 8 September in Boston

The early-bird registration deadline for the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance (AMR) is 26 July 2017. Co-sponsored by the American Society for Microbiology (ASM) and ESCMID, this leading conference will provide a unique forum for you to explore the challenges, opportunities and current requirements for antimicrobial drug development to tackle AMR.

› Read more

CMI highlight: antibiotic innovation for future public health needs

Ursula Theuretzbacher urges the scientific community to use the term ‘innovation’ in a narrower sense in the context of research and development into novel antibiotics. The term is traditionally used in a broader sense to describe any novel class of drugs, target or mode of action. Regarding antimicrobials, however, she proposes to restrict the term to drugs that possess the potential to tackle resistance, i.e. compounds that are unlikely to be impacted by cross-resistance with existing therapies and that have a low potential for high-frequency high-level single-step resistance. An independent international expert panel should agree on the most predictive tests and detailed scientific criteria to define all biological aspects of ‘innovation’.

› Read more

Reminder: call for abstracts for vaccine conference

The abstract submission for the 4th Conference on Vaccines: new and old Diseases in adults and children – unmet needs is still open until 23 July 2017. The conference from 8 – 10 September 2017 in Dubrovnik, Croatia, is set to bring together leading experts who will present and debate the most recent data to develop strategies that will help protect generations to come from vaccine-preventable diseases. The target audience are specialists or physicians in training in infectious diseases, clinical microbiology, hygiene, public health, vaccinology and other disciplines dealing with all aspects of vaccination.

› Read more

BioMérieux is looking for medical/scientific expert near Lyon

The French company specialized in in vitro diagnostics has an opening for a Medical and Scientific Advisor in Marcy-l'Étoile, not far from Lyon. The ideal candidate is a medical doctor, and/or PhD with relevant experience in the clinical field and with a good knowledge of hospital/ medical environment, particularly in infectious diseases and microbiology. Experience and knowledge of in vitro diagnostics and clinical trials is a must.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.